| Zion's Way Hospice 1664 South Dixie Drive, Suite E-102, St George, UT, 84770 | |
| (435) 688-0648 |
News Archive
The Boston Globe on Sunday examined the funding approach of the Bill & Melinda Gates Foundation, which has a $31.9 billion endowment and a commitment of $30 billion from Berkshire Hathaway Chair Warren Buffett.
Gastric carcinoma is one of the most common causes of cancer-related deaths, primarily because most patients present at an advanced stage of the disease.
Around 25 per cent, or more than 3,000 of the 13,000 bowel cancers diagnosed in Australia every year could be prevented if men and women maintained a healthy body weight, ate a healthy diet and engaged in daily physical activity.
Cardica, Inc. (Nasdaq: CRDC) today announced that, on September 2, 2009, it received a notice from the Listing Qualifications Department of The NASDAQ Global Market (NASDAQ) stating that the Company's stock will be delisted from NASDAQ based upon NASDAQ staff's determination that Cardica has not regained compliance with the minimum $10 million stockholders' equity requirement for continued listing on the NASDAQ as stated under NASDAQ Marketplace Rule 5450(b)(1)(A).
An extended release generic nifedipine product (Mylan-Nifedipine extended release 60 mg formerly Gen-Nifedipine extended release 60mg, Genpharm ULC) is not bioequivalent to the Canadian originator product, Adalat(R) XL(R), according to the results of a study recently published in the International Journal of Clinical Pharmacology and Therapeutics.
› Verified 4 days ago
| Name | Zion's Way Hospice |
|---|---|
| Location | 1664 South Dixie Drive, Suite E-102, St George, Utah |
| Hospice ID | 461559 |
| Category | Part of a Home Health Agency |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| SSA county code | 260 |
News Archive
The Boston Globe on Sunday examined the funding approach of the Bill & Melinda Gates Foundation, which has a $31.9 billion endowment and a commitment of $30 billion from Berkshire Hathaway Chair Warren Buffett.
Gastric carcinoma is one of the most common causes of cancer-related deaths, primarily because most patients present at an advanced stage of the disease.
Around 25 per cent, or more than 3,000 of the 13,000 bowel cancers diagnosed in Australia every year could be prevented if men and women maintained a healthy body weight, ate a healthy diet and engaged in daily physical activity.
Cardica, Inc. (Nasdaq: CRDC) today announced that, on September 2, 2009, it received a notice from the Listing Qualifications Department of The NASDAQ Global Market (NASDAQ) stating that the Company's stock will be delisted from NASDAQ based upon NASDAQ staff's determination that Cardica has not regained compliance with the minimum $10 million stockholders' equity requirement for continued listing on the NASDAQ as stated under NASDAQ Marketplace Rule 5450(b)(1)(A).
An extended release generic nifedipine product (Mylan-Nifedipine extended release 60 mg formerly Gen-Nifedipine extended release 60mg, Genpharm ULC) is not bioequivalent to the Canadian originator product, Adalat(R) XL(R), according to the results of a study recently published in the International Journal of Clinical Pharmacology and Therapeutics.
› Verified 4 days ago
| NPI Number | 1477649606 |
| Organization Name | Zion's Way, Inc. |
| Address | 912 W 1600 S St George, Utah, 84770 |
| Phone Number | (435)688-0648 |
News Archive
The Boston Globe on Sunday examined the funding approach of the Bill & Melinda Gates Foundation, which has a $31.9 billion endowment and a commitment of $30 billion from Berkshire Hathaway Chair Warren Buffett.
Gastric carcinoma is one of the most common causes of cancer-related deaths, primarily because most patients present at an advanced stage of the disease.
Around 25 per cent, or more than 3,000 of the 13,000 bowel cancers diagnosed in Australia every year could be prevented if men and women maintained a healthy body weight, ate a healthy diet and engaged in daily physical activity.
Cardica, Inc. (Nasdaq: CRDC) today announced that, on September 2, 2009, it received a notice from the Listing Qualifications Department of The NASDAQ Global Market (NASDAQ) stating that the Company's stock will be delisted from NASDAQ based upon NASDAQ staff's determination that Cardica has not regained compliance with the minimum $10 million stockholders' equity requirement for continued listing on the NASDAQ as stated under NASDAQ Marketplace Rule 5450(b)(1)(A).
An extended release generic nifedipine product (Mylan-Nifedipine extended release 60 mg formerly Gen-Nifedipine extended release 60mg, Genpharm ULC) is not bioequivalent to the Canadian originator product, Adalat(R) XL(R), according to the results of a study recently published in the International Journal of Clinical Pharmacology and Therapeutics.
› Verified 4 days ago
| NPI Number | 1669746525 |
| Organization Name | Red Rock Healthcare, Inc. |
| Address | 1664 S Dixie Dr St George, Utah, 84770 |
| Phone Number | (435)688-0648 |
News Archive
The Boston Globe on Sunday examined the funding approach of the Bill & Melinda Gates Foundation, which has a $31.9 billion endowment and a commitment of $30 billion from Berkshire Hathaway Chair Warren Buffett.
Gastric carcinoma is one of the most common causes of cancer-related deaths, primarily because most patients present at an advanced stage of the disease.
Around 25 per cent, or more than 3,000 of the 13,000 bowel cancers diagnosed in Australia every year could be prevented if men and women maintained a healthy body weight, ate a healthy diet and engaged in daily physical activity.
Cardica, Inc. (Nasdaq: CRDC) today announced that, on September 2, 2009, it received a notice from the Listing Qualifications Department of The NASDAQ Global Market (NASDAQ) stating that the Company's stock will be delisted from NASDAQ based upon NASDAQ staff's determination that Cardica has not regained compliance with the minimum $10 million stockholders' equity requirement for continued listing on the NASDAQ as stated under NASDAQ Marketplace Rule 5450(b)(1)(A).
An extended release generic nifedipine product (Mylan-Nifedipine extended release 60 mg formerly Gen-Nifedipine extended release 60mg, Genpharm ULC) is not bioequivalent to the Canadian originator product, Adalat(R) XL(R), according to the results of a study recently published in the International Journal of Clinical Pharmacology and Therapeutics.
› Verified 4 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 94.7 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 80.1 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 93.0 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 87.7 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 88.3 | 97.3 |
| Patients who got timely treatment for shortness of breath | 82.6 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 89.6 | 93.3 |
News Archive
The Boston Globe on Sunday examined the funding approach of the Bill & Melinda Gates Foundation, which has a $31.9 billion endowment and a commitment of $30 billion from Berkshire Hathaway Chair Warren Buffett.
Gastric carcinoma is one of the most common causes of cancer-related deaths, primarily because most patients present at an advanced stage of the disease.
Around 25 per cent, or more than 3,000 of the 13,000 bowel cancers diagnosed in Australia every year could be prevented if men and women maintained a healthy body weight, ate a healthy diet and engaged in daily physical activity.
Cardica, Inc. (Nasdaq: CRDC) today announced that, on September 2, 2009, it received a notice from the Listing Qualifications Department of The NASDAQ Global Market (NASDAQ) stating that the Company's stock will be delisted from NASDAQ based upon NASDAQ staff's determination that Cardica has not regained compliance with the minimum $10 million stockholders' equity requirement for continued listing on the NASDAQ as stated under NASDAQ Marketplace Rule 5450(b)(1)(A).
An extended release generic nifedipine product (Mylan-Nifedipine extended release 60 mg formerly Gen-Nifedipine extended release 60mg, Genpharm ULC) is not bioequivalent to the Canadian originator product, Adalat(R) XL(R), according to the results of a study recently published in the International Journal of Clinical Pharmacology and Therapeutics.
› Verified 4 days ago
| Home Health Aides | 10 |
| Counselors | 1.5 |
| Licensed Practical or Vocational Nurses | 1.5 |
| Medical Social Workers | 3 |
| Physicians | 3 |
| Registered Nurses | 18 |
| Other Personnel | 17 |
| Total Employees | 54 |
|---|
News Archive
The Boston Globe on Sunday examined the funding approach of the Bill & Melinda Gates Foundation, which has a $31.9 billion endowment and a commitment of $30 billion from Berkshire Hathaway Chair Warren Buffett.
Gastric carcinoma is one of the most common causes of cancer-related deaths, primarily because most patients present at an advanced stage of the disease.
Around 25 per cent, or more than 3,000 of the 13,000 bowel cancers diagnosed in Australia every year could be prevented if men and women maintained a healthy body weight, ate a healthy diet and engaged in daily physical activity.
Cardica, Inc. (Nasdaq: CRDC) today announced that, on September 2, 2009, it received a notice from the Listing Qualifications Department of The NASDAQ Global Market (NASDAQ) stating that the Company's stock will be delisted from NASDAQ based upon NASDAQ staff's determination that Cardica has not regained compliance with the minimum $10 million stockholders' equity requirement for continued listing on the NASDAQ as stated under NASDAQ Marketplace Rule 5450(b)(1)(A).
An extended release generic nifedipine product (Mylan-Nifedipine extended release 60 mg formerly Gen-Nifedipine extended release 60mg, Genpharm ULC) is not bioequivalent to the Canadian originator product, Adalat(R) XL(R), according to the results of a study recently published in the International Journal of Clinical Pharmacology and Therapeutics.
› Verified 4 days ago
| Intermountain Homecare Hospice, St George Location: 555 South Bluff Street, Suite 100, St George, Utah, 84770 Phone: (435) 688-0648 |
| Encompass Hospice Of Southern Utah Location: 640 East 700 South, Suite 101, St George, Utah, 84770 Phone: (435) 688-0648 |
| Applegate Hospice Location: 1490 East Foremaster Drive, Suite 340, St George, Utah, 84790 Phone: (435) 688-0648 |
| Horizon Hospice Specialists - Sg Location: 292 South 1470 East, Suite 101, St George, Utah, 84790 Phone: (435) 688-0648 |